antalerg unimed pharma 0,05% eye drops, solution
unimed pharma - Азеластин - 0,05% eye drops, solution
sensilux unimed pharma 0.5 mg/ml eye drops, solution
unimed pharma ltd. - tetryzoline - 0.5 mg/ml eye drops, solution
potassium iodide unimed pharma 2% eye drops, solution
unimed pharma - Калиев Йодид - 2% eye drops, solution
natalizumab elan pharma
elan pharma international ltd. - натализумаб - Болест на Крон - Иммуностимуляторы, - Лечение на умерено силно активна болест на Крон за намаляване на признаци и симптоми, и по индукция и поддържане на устойчиво отговор и на ремисия при пациенти, които не е отговорено, въпреки пълен и адекватен курс на лечение с кортикостероиди и иммунодепрессанты; или непоносимост или има противопоказания за такава терапия.
novocillin lc 1000 mg интрамамарна суспензия за крави в лактационен период 1000 mg/10 g
pharmanovo veterinärarzneimittel gmbh - oxacillin sodium - интрамамарна суспензия - 1000 mg/10 g - крави
indapen sr 1,5 mg prolonged - release tablets
pharmaceutical works polpharma sa - Индапамид - 1,5 mg prolonged - release tablets
mezoprele 20 mg gastro-resistant capsules
pharmaceutical works polpharma sa - Езомепразол - 20 mg gastro-resistant capsules
mezoprele 40 mg gastro-resistant capsules
pharmaceutical works polpharma sa - Езомепразол - 40 mg gastro-resistant capsules
linezolid polpharma 2 mg/ml solution for infusion
pharmaceutical works polpharma sa - Линезолид - 2 mg/ml solution for infusion
clopidogrel viatris (previously clopidogrel taw pharma)
viatris limited - клопидогрел безилат - peripheral vascular diseases; stroke; myocardial infarction - Антитромботични агенти - secondary prevention of atherothrombotic events clopidogrel is indicated in:adult patients suffering from myocardial infarction (from a few days until less than 35 days), ischemic stroke (from 7 days until less than 6 months) or established peripheral arterial disease. adult patients suffering from acute coronary syndrome. non-st segment elevation acute coronary syndrome (unstable angina or non-q-wave myocardial infarction), including patients undergoing a stent placement following percutaneous coronary intervention, in combination with acetylsalicylic acid (asa). Възхода на сегмента st остър инфаркт на миокарда, в комбинация с ВЪЗХОДЯЩО в лечението на пациенти, които имат право на тромболитической терапия. in patients with moderate to high-risk transient ischaemic attack (tia) or minor ischaemic stroke (is) clopidogrel in combination with asa is indicated in:adult patients with moderate to high-risk tia (abcd2 score ≥4) or minor is (nihss ≤3) within 24 hours of either the tia or is event. prevention of atherothrombotic and thromboembolic events in atrial fibrillation:in adult patients with atrial fibrillation who have at least one risk factor for vascular events, are not suitable for treatment with vitamin k antagonists (vka) and who have a low bleeding risk, clopidogrel is indicated in combination with asa for the prevention of atherothrombotic and thromboembolic events, including stroke. За повече информация, моля, вижте раздел 5.